Is Pomegranate Good for Your Liver and Kidneys?

Pomegranate shows genuine promise for both liver and kidney health, but the evidence is lopsided: dozens of animal studies consistently demonstrate protective effects, while human clinical data remains thin. In animal models, pomegranate juice, extract, and individual compounds have reduced liver enzyme levels, curbed fat buildup in the liver, and shielded kidneys from drug-induced damage and stone formation. A handful of human trials, particularly in people with fatty liver disease and those on hemodialysis, echo these findings. The picture is encouraging enough that researchers keep pursuing it, but not yet strong enough to call pomegranate a treatment for any liver or kidney condition.

What the Liver Evidence Actually Shows

The strongest case for pomegranate’s liver benefits comes from animal experiments modeling conditions that damage the liver in specific, well-understood ways. In rats fed a high-fat diet to induce fatty liver, pomegranate extract inhibited fat accumulation in liver tissue and reduced blood lipid levels.¹ When rats were given pomegranate juice alongside a high-fat diet designed to cause fatty liver, the juice group had markedly less liver inflammation, less scarring, and lower levels of liver enzymes (ALT and AST) in their blood, which are standard markers of liver damage.² In a model of chemical-induced liver injury, pomegranate protected against fibrosis by dialing down inflammatory pathways and boosting the liver’s own antioxidant defenses.³ Even paracetamol (acetaminophen) poisoning, a common cause of acute liver failure in humans, was partially blunted in rats pre-treated with pomegranate juice.⁴

What makes these findings more interesting than a typical “superfood” hype cycle is that they converge on a consistent mechanism. Pomegranate compounds activate a protein called Nrf2, which acts as a master switch for the body’s antioxidant defense system. When Nrf2 is turned on, cells ramp up production of protective enzymes that neutralize the reactive molecules that cause tissue damage. Multiple studies have confirmed that blocking Nrf2 erases pomegranate’s protective effects, which means the benefit is not just coincidence but is running through a specific biological pathway.⁵ In a rat model of liver cancer, pomegranate extract elevated Nrf2 levels and the antioxidant genes it controls, providing chemoprevention without signs of toxicity.⁶

Human Trials on Liver Health

The leap from rats to people is where the evidence gets thinner but not absent. A randomized, double-blind trial in people with non-alcoholic fatty liver disease found that pomegranate extract significantly reduced ALT, AST, and GGT levels compared to placebo. It also lowered fetuin-A and FGF-21, two proteins tied to liver fat metabolism and inflammation, along with the inflammatory marker IL-6.⁷ That trial is one of the few controlled human experiments directly testing pomegranate for fatty liver, and its results were positive across multiple markers.

A separate controlled trial looked at men with type 2 diabetes who combined pomegranate juice intake with aerobic exercise over eight weeks. The combination lowered liver enzymes and insulin resistance more than either exercise or juice alone.⁸ The practical takeaway here is worth noting: pomegranate juice appeared to amplify the liver benefits of exercise rather than replacing it. For someone managing diabetes-related liver strain, that synergy could matter.

Two human trials is not a foundation for clinical recommendations, even if both pointed in the right direction. Fatty liver disease alone affects roughly a quarter of adults worldwide, so the need for accessible interventions is real. But larger and longer trials are needed before anyone should think of pomegranate as a treatment rather than a potentially helpful dietary habit.

Kidney Protection in Animal Models

The kidney story runs parallel to the liver story: animal evidence is plentiful and consistent, human evidence is limited but encouraging. Several studies have tested pomegranate against drug-induced kidney damage, the kind that occurs as a side effect of certain antibiotics and chemotherapy agents. Pomegranate flower extract given to rats alongside the antibiotic gentamicin significantly reduced markers of kidney toxicity, including creatinine and blood urea nitrogen, while also limiting tissue damage and weight loss.⁹ Pomegranate seed oil showed a similar protective pattern against cisplatin, a chemotherapy drug notorious for kidney damage, reducing urinary protein and creatinine levels in rats.¹⁰

Ischemia-reperfusion injury, where blood flow to the kidney is cut off and then restored (a common problem in surgery and transplantation), has also been a target. Pomegranate extract pretreatment reduced the tissue death and oxidative damage caused by this type of injury in multiple rat studies.¹¹ The protective mechanism again traced back to suppression of inflammatory signaling and boosting of antioxidant levels.¹² In diabetic rats, pomegranate peel extract reduced blood sugar, kidney toxicity markers, and the scarring of kidney filtering units that characterizes diabetic kidney disease.¹³

Pomegranate and Kidney Stones

Kidney stones are one area where pomegranate’s reputation has some direct experimental backing. In rats given ethylene glycol to induce calcium oxalate stone formation, those also receiving pomegranate juice showed limited or no crystal formation in their kidneys, compared to severe crystallization and cell damage in the untreated group.¹⁴ Lab testing of pomegranate compounds has shown they can inhibit calcium oxalate crystal formation at both the nucleation and aggregation stages, with inhibition rates above 88% for aggregation and above 98% for nucleation.¹⁵

A small human pilot study in recurrent stone formers tested pomegranate extract supplementation and found it did not increase stone risk and showed a trend toward decreasing calcium oxalate supersaturation, the chemical condition that favors stone formation. The researchers were careful to note that the study could not determine whether pomegranate actually prevents stones, but the safety signal was reassuring: people prone to stones were not made worse by it.¹⁶ Given that many fruits high in oxalates can actually promote stones, the fact that pomegranate appears neutral-to-beneficial is worth knowing for people who worry about stone recurrence.

What the Hemodialysis Trials Found

Some of the best human kidney data comes from an unexpected population: people on hemodialysis. Dialysis patients face chronic oxidative stress and inflammation, and they are at elevated risk for cardiovascular disease and infections. Several controlled trials have tested pomegranate juice in this group with broadly positive results.

A year-long randomized placebo-controlled trial gave hemodialysis patients pomegranate juice three times per week during their dialysis sessions. By the end, the juice group had lower oxidative stress markers, reduced inflammation, and fewer hospitalizations due to infections. A quarter of the pomegranate group showed improvement in their atherosclerotic burden, while over half of the placebo group showed progression and none showed improvement.¹⁷ These benefits disappeared within three months of stopping the juice, suggesting the effect requires ongoing intake.

A separate crossover trial confirmed that pomegranate juice increased total antioxidant capacity while decreasing markers of both oxidative damage and inflammation in hemodialysis patients. The changes were significantly different from the control period.¹⁸ Another trial found that pomegranate juice prevented the spike in oxidative stress that normally occurs when intravenous iron is given during dialysis sessions.¹⁹

The hemodialysis findings stand out because they are multiple controlled trials in humans, not just animal work. The consistent reduction in oxidative stress and inflammation is clinically relevant for a population that desperately needs cardiovascular risk reduction. That said, dialysis patients should consult their care team before adding pomegranate juice, for reasons covered in the safety section below.

Diabetic Kidney Disease in Humans

Diabetic kidney disease is a leading cause of kidney failure, and one clinical trial has specifically tested pomegranate in this population. A double-blind randomized trial gave pomegranate juice powder to patients with diabetic nephropathy who were already receiving standard treatment. After four and eight weeks, the intervention group had significantly reduced urine albumin-to-creatinine ratio and urine albumin, two key indicators of kidney damage progression, compared to both their own baseline and the placebo group.²⁰ The authors described it as the first clinical trial investigating pomegranate specifically for diabetic nephropathy and noted a promising role as a supplement alongside standard care.

Why Urolithins Matter

You do not absorb most of pomegranate’s key polyphenols directly. The large ellagitannin molecules, including punicalagin, are broken down by your gut bacteria into smaller compounds called urolithins, which are far better absorbed into the bloodstream.²¹ This means your gut microbiome composition affects how much benefit you get from pomegranate. People with different gut bacteria produce different amounts of urolithins, which partly explains why the same dose of pomegranate can have variable effects across individuals.

Urolithin A, the most studied of these metabolites, has its own growing body of research. A recent study found that urolithin A protected against calcium oxalate crystal formation and kidney injury by restoring a cellular cleanup process called mitophagy, where cells recycle their damaged energy-producing components.²² This adds an interesting layer: pomegranate’s kidney benefits may not come from the fruit’s compounds directly but from what your gut bacteria make out of them.

Blood Pressure and the Kidney Connection

High blood pressure is both a cause and a consequence of kidney disease, so anything that lowers blood pressure can indirectly benefit the kidneys. A small human study found that pomegranate juice consumption reduced serum ACE activity by about 36% and lowered systolic blood pressure by about 5%.²³ ACE is the same enzyme targeted by ACE inhibitor drugs, which are among the first-line treatments for protecting kidney function in people with hypertension or diabetes. Pomegranate’s ability to mildly inhibit this enzyme is interesting, though a 5% blood pressure drop is modest compared to medication. It also raises a practical concern: if you are already taking an ACE inhibitor or an ARB for kidney protection, adding pomegranate could theoretically amplify the blood pressure effect in ways your doctor should know about.

Safety, Drug Interactions, and Potassium

Pomegranate is broadly safe for most people. A formal toxicity assessment in animals found no adverse effects at doses up to 600 mg per kilogram of body weight per day, and human safety studies using pomegranate extract at various doses for 28 days reported no serious adverse events on blood counts, blood chemistry, or urinalysis.²⁴ At high doses (around 3,000 mg of extract), diarrhea has been reported more frequently.²⁵

The more serious concern involves drug interactions. Pomegranate constituents inhibit two families of liver enzymes, CYP3A4 and CYP2C9, that metabolize a wide range of medications. This means pomegranate juice could slow the breakdown of drugs processed by these enzymes, effectively increasing the drug’s concentration in your blood.²⁶ Statins, certain blood pressure medications, blood thinners like warfarin, and some immunosuppressants are all processed through these enzyme pathways. If you take any prescription medications regularly, this interaction is worth discussing with your pharmacist or doctor before adding pomegranate juice or supplements to your routine.

For people with advanced kidney disease, potassium is the elephant in the room. Pomegranate juice is moderately high in potassium, and kidneys that are not functioning well cannot clear excess potassium efficiently. Dangerous potassium levels can cause heart rhythm problems. The hemodialysis trials described earlier did monitor for this and did not report potassium-related adverse events, but those were supervised clinical settings. Anyone with significantly reduced kidney function should have their potassium levels monitored if they start drinking pomegranate juice regularly.

Juice, Extract, or Whole Fruit

A comparison study in humans found that pomegranate juice, a liquid extract, and a powdered extract all delivered similar levels of ellagitannin metabolites into the blood and urine. The main difference was timing: the powdered extract took longer to reach peak blood levels (about two and a half hours) compared to juice or liquid extract (under an hour).²⁷ So from a bioavailability standpoint, all three forms appear roughly equivalent. The practical differences are sugar content (juice carries calories and sugar that extracts do not), cost, and convenience.

Product quality is a real concern. An analysis of commercial pomegranate juices using a multidimensional authenticity test found that only 6 of 23 products strictly met all authenticity criteria.²⁸ Adulteration with cheaper juices, added sugar, and filler ingredients is widespread. If you are drinking pomegranate juice for its polyphenol content rather than just its taste, choosing 100% pomegranate juice from a reputable brand matters more than most consumers realize. For supplements, the lack of standardized labeling makes it even harder to know what you are getting. Looking for products that specify punicalagin or ellagic acid content is one way to compare, though verification remains difficult without independent testing.

Where Different Parts of the Fruit Come In

Research has not limited itself to pomegranate juice. The peel, seeds, and even the flowers contain distinct compound profiles and have shown different protective effects. Pomegranate peel and seed extracts reduced markers of liver fibrosis in rats exposed to a liver toxin, lowering levels of compounds involved in scar tissue formation.²⁹ Pomegranate flower extract protected rat kidneys against antibiotic-induced toxicity, as mentioned earlier. The peel is particularly rich in punicalagin and ellagic acid, while the seed oil contains punicic acid, a type of conjugated fatty acid. Most commercial juices include compounds pressed from the peel during processing, which is part of why juice tends to be so rich in polyphenols compared to just eating the seeds. If you eat the arils alone, you get the seed’s nutrients but miss much of the peel’s ellagitannin content.

This matters because the part of the pomegranate used in a study determines what compounds are being tested. A study using seed oil is testing a different chemical profile than one using juice or peel extract. When someone says “pomegranate is good for your kidneys,” they are collapsing results from different preparations into one statement. The overall picture is favorable across preparations, but the details vary.